Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
Due to the alarming spread of bacterial resistance to conventional drugs, the sole use of antibiotics to fight lung infections in cystic fibrosis (CF) is not resolutive, and novel strategies to replace or complement the use of antibiotics are highly desirable. Among these strategies, the use of prob...
Main Authors: | Giovanna Batoni, Giuseppantonio Maisetta, Esingül Kaya, Semih Esin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/3/326 |
Similar Items
-
<i>Lactobacillus</i> Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of <i>Pseudomonas aeruginosa</i> from Cystic Fibrosis Lung
by: Giovanna Batoni, et al.
Published: (2023-06-01) -
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
by: Gabriella d'Ettorre, et al.
Published: (2020-07-01) -
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of <i>Pseudomonas aeruginosa</i> under Conditions Relevant to Cystic Fibrosis
by: Giovanna Batoni, et al.
Published: (2023-07-01) -
Convergence of Nanotechnology and Bacteriotherapy for Biomedical Applications
by: Jun Liu, et al.
Published: (2024-04-01) -
Bacteriotherapy for inflammatory bowel disease
by: Yusuke Yoshimatsu, et al.
Published: (2021-01-01)